Category, n (%) | N = 4491 |
---|---|
ICS/LABA | 1054 (23.5) |
LTRA | 96 (2.1) |
THO | 4 (0.1) |
SABA | 15 (0.3) |
LAMA/SAMA | 4 (0.1) |
ICS | 8 (0.2) |
Other single drug | 10 (0.2) |
ICS/LABA + other combined drugsa | 2997 (66.7) |
ICS/LABA + LTRA + THO + SABA + others | 49 (1.1) |
ICS/LABA + LTRA + THO + others | 374 (8.3) |
ICS/LABA + LTRA + SABA + others | 200 (4.5) |
ICS/LABA + LTRA + others | 1833 (40.8) |
ICS/LABA + THO + others | 159 (3.5) |
ICS/LABA + THO + SABA + others | 11 (0.2) |
ICS/LABA + SABA + others | 100 (2.2) |
ICS/LABA + others | 271 (6.0) |
LTRA + other combined drugsb | 236 (5.3) |
THO + other combined drugsc | 16 (0.) |
Other combined drugs | 30 (0.7) |